S&P 500   3,120.18 (-0.06%)
DOW   27,934.02 (-0.36%)
QQQ   203.37 (+0.15%)
CGC   15.32 (+7.74%)
BABA   185.25 (+0.35%)
GE   11.50 (+0.52%)
ACB   2.33 (+2.19%)
PRI   131.64 (+0.41%)
BAC   32.95 (-0.03%)
S&P 500   3,120.18 (-0.06%)
DOW   27,934.02 (-0.36%)
QQQ   203.37 (+0.15%)
CGC   15.32 (+7.74%)
BABA   185.25 (+0.35%)
GE   11.50 (+0.52%)
ACB   2.33 (+2.19%)
PRI   131.64 (+0.41%)
BAC   32.95 (-0.03%)
S&P 500   3,120.18 (-0.06%)
DOW   27,934.02 (-0.36%)
QQQ   203.37 (+0.15%)
CGC   15.32 (+7.74%)
BABA   185.25 (+0.35%)
GE   11.50 (+0.52%)
ACB   2.33 (+2.19%)
PRI   131.64 (+0.41%)
BAC   32.95 (-0.03%)
S&P 500   3,120.18 (-0.06%)
DOW   27,934.02 (-0.36%)
QQQ   203.37 (+0.15%)
CGC   15.32 (+7.74%)
BABA   185.25 (+0.35%)
GE   11.50 (+0.52%)
ACB   2.33 (+2.19%)
PRI   131.64 (+0.41%)
BAC   32.95 (-0.03%)
Log in

Natus Medical Stock Price, Forecast & Analysis (NASDAQ:BABY)

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range N/A
50-Day Range
$26.75
MA: $29.96
$31.92
52-Week Range N/A
Volume289,334 shs
Average Volume165,325 shs
Market Capitalization$1.09 billion
P/E Ratio22.48
Dividend YieldN/A
Beta0.57
Natus Medical Incorporated provides neurology, newborn care, and hearing and balance assessment healthcare products and services worldwide. It offers products and services used for the screening, diagnosis, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction and neurosurgical treatments, epilepsy, sleep disorders, neuromuscular diseases, and balance and mobility disorders. Read More…

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:BABY
CUSIP63905010
Phone925-223-6700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$530.89 million
Book Value$11.80 per share

Profitability

Net Income$-22,930,000.00

Miscellaneous

Employees1,729
Market Cap$1.09 billion
Next Earnings Date2/11/2020 (Estimated)
OptionableOptionable

Receive BABY News and Ratings via Email

Sign-up to receive the latest news and ratings for BABY and its competitors with MarketBeat's FREE daily newsletter.


Natus Medical (NASDAQ:BABY) Frequently Asked Questions

What is Natus Medical's stock symbol?

Natus Medical trades on the NASDAQ under the ticker symbol "BABY."

How will Natus Medical's stock buyback program work?

Natus Medical announced that its Board of Directors has authorized a stock repurchase program on Thursday, February 22nd 2018, which allows the company to repurchase $30,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to reacquire shares of its stock through open market purchases. Stock repurchase programs are usually a sign that the company's board believes its stock is undervalued.

How were Natus Medical's earnings last quarter?

Natus Medical Inc (NASDAQ:BABY) issued its quarterly earnings data on Wednesday, October, 24th. The medical equipment provider reported $0.40 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.42 by $0.02. The medical equipment provider had revenue of $130.60 million for the quarter, compared to the consensus estimate of $132.92 million. Natus Medical had a positive return on equity of 10.79% and a negative net margin of 7.38%. The firm's revenue for the quarter was up 6.5% compared to the same quarter last year. During the same quarter last year, the company earned $0.40 earnings per share. View Natus Medical's Earnings History.

When is Natus Medical's next earnings date?

Natus Medical is scheduled to release their next quarterly earnings announcement on Tuesday, February 11th 2020. View Earnings Estimates for Natus Medical.

What is the consensus analysts' recommendation for Natus Medical?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Natus Medical in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Natus Medical.

Has Natus Medical been receiving favorable news coverage?

Press coverage about BABY stock has been trending very negative recently, InfoTrie reports. The research group identifies positive and negative news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Natus Medical earned a media sentiment score of -3.4 on InfoTrie's scale. They also assigned media headlines about the medical equipment provider a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the next few days. View News Stories for Natus Medical.

Who are some of Natus Medical's key competitors?

What other stocks do shareholders of Natus Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Natus Medical investors own include Starbucks (SBUX), Activision Blizzard (ATVI), Walt Disney (DIS), Gilead Sciences (GILD), Intel (INTC), Skyworks Solutions (SWKS), Celgene (CELG), Alphabet (GOOG), NVIDIA (NVDA) and Tesla (TSLA).

Who are Natus Medical's key executives?

Natus Medical's management team includes the folowing people:
  • Mr. Jonathan A. Kennedy CPA, Pres, CEO & Director (Age 48)
  • Mr. Benjamin Drew Davies, Exec. VP & CFO (Age 53)
  • Mr. Austin F. Noll III, Exec. VP & Chief Commercial Officer (Age 52)
  • Mr. Seán Langan, VP Global Operations
  • Mr. Ivan Pandiyan, VP of Global R&D

How big of a company is Natus Medical?

Natus Medical has a market capitalization of $0.00 and generates $530.89 million in revenue each year. The medical equipment provider earns $-22,930,000.00 in net income (profit) each year or $1.42 on an earnings per share basis. Natus Medical employs 1,729 workers across the globe.View Additional Information About Natus Medical.

What is Natus Medical's official website?

The official website for Natus Medical is http://www.natus.com/.

How can I contact Natus Medical?

Natus Medical's mailing address is 6701 KOLL CENTER PARKWAY SUITE 120, PLEASANTON CA, 94566. The medical equipment provider can be reached via phone at 925-223-6700 or via email at [email protected]


MarketBeat Community Rating for Natus Medical (NASDAQ BABY)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  283 (Vote Outperform)
Underperform Votes:  308 (Vote Underperform)
Total Votes:  591
MarketBeat's community ratings are surveys of what our community members think about Natus Medical and other stocks. Vote "Outperform" if you believe BABY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BABY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/19/2019 by MarketBeat.com Staff

Featured Article: Day Trading

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel